Skip to main content

Patient-Centric Design of Long-Acting Injectable Drug Products

Long-Acting Injectables (LAIs) are rapidly growing across the pharmaceutical industry for the treatment of chronic conditions, infectious diseases (HIV, Malaria, TB, Hepatitis C, etc.), antipsychotic drugs, hormonal contraceptives, bone health, cancer, etc., because they offer the opportunity to reduce administration frequency, improve patience adherence and experience, and reduce healthcare costs. A recent example on the impact of LAI regimens to patients comes from the FDA approval of Cabenuva, an extended-release dosage of Cabotegravir and Rilpivirine for the treatment of HIV. Other key cross-pharma collaborations highlight the intense activity in the area.

However, the path for design and development of LAIs is not as defined as it is for other dosage forms (e.g. oral solid dosage forms). At this stage, there is a need for experts in the field across the pharmaceutical, regulatory, and academic landscape to work together to identify gaps and defining strategies to accelerate the development of this game-changing class of drug products.

The LAI Drug Product Design and Development space should be brought to the same level as the oral solid dosage forms space, with clear regulatory guidelines (e.g. BCS classification, ICH M9), defined mechanistic understanding, predictive simulation tools (e.g., PBPK modeling), and biorelevant dissolution methods.

You may purchase the entire workshop series or just an individual session(s). To purchase the full series, please click the Add to Cart button below. To add a single session, please click on the video link below and add that the individual video to your shopping cart. All registrants will have access to the session slides and recordings post-event.

Cancellation Policy
Cancellations must be made in writing and emailed to and will be honored as follows:
AAPS will issue a refund to any attendee who cancels at least three (3) business days in advance of the event:

  • If you cancel your registration on/before March 4, 2022 you will be refunded your registration fees minus an administrative fee of $50 for members/non-members or $25 for students.
  • In the case of a multi-day event, cancellation must be received no later than 3 business days before the first scheduled webinar date/start time.
  • Cancellations received less on/after March 4, 2022 will not be refunded.
  • In the rare event that AAPS must to cancel due to circumstances beyond our control, we will make every effort to notify attendees as quickly as possible. Attendees will be given the opportunity to either transfer to another webinar or obtain a full refund.
No refunds will be given for “no shows” or for attendee technology problems. It is the responsibility of the attendee to test their computer setup before the start of the webinar. If a technical failure at your home or workplace prevents access to the live event, you are not eligible for a refund. If the technical problem is due to our error, we will issue a refund.

Group Registration
Bring four or more paid full conference attendees from the same company and receive a 15% discount per full conference registration. This offer cannot be used with other discounted offers (e.g. speaker rate, complimentary sponsor passes, student rates, etc.). Please email for your discount code. The deadline to redeem is March 7, 2021. If your group does not meet the minimum requirement, AAPS reserves the right to alter your registration fee.

Thank you to our sponsors: